NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

FOXO

FOXO Technologies Inc

Jun 30 • 04:00PM ET

0.1821

Dollar change -0.0049
Percentage change -2.62	%

Healthcare • Health Information Services • USA • AMEX

Peers: ILMN EXAS QGEN TXG ONC GH MYGN CDNA PACB TWST

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-7.93	Insider Own	3.18%	Shs Outstand	10.62M	Perf Week	-8.95%
Market Cap	3.67M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	10.28M	Perf Month	-57.96%
Enterprise Value	-	PEG	-	EPS next Q	-	Inst Own	0.46%	Short Float	3.78%	Perf Quarter	-88.54%
Income	-12.42M	P/S	0.51	EPS this Y	-	Inst Trans	437.64%	Short Ratio	0.07	Perf Half Y	-95.46%
Sales	7.21M	P/B	0.06	EPS next Y	-	ROA	-51.34%	Short Interest	0.39M	Perf YTD	-93.75%
Book/sh	2.84	P/C	-	EPS next 5Y	-	ROE	-	52W High	13.00 -98.60%	Perf Year	-92.93%
Cash/sh	-	P/FCF	-	EPS past 3/5Y	75.88% -7.61%	ROIC	-127.96%	52W Low	0.17 4.06%	Perf 3Y	-99.98%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.02% 10.74%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	87.76%	Oper. Margin	-87.30%	ATR (14)	0.05	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	-	Sales Y/Y TTM	2639.81%	Profit Margin	-172.42%	RSI (14)	27.46	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.11	EPS Q/Q	84.81%	SMA20	-31.48%	Beta	3.06	Target Price	-
Payout	-	Debt/Eq	0.30	Sales Q/Q	39918.93%	SMA50	-68.41%	Rel Volume	0.66	Prev Close	0.19
Employees	-	LT Debt/Eq	0.00	Earnings	-	SMA200	-91.45%	Avg Volume	5.98M	Price	0.18
IPO	Jan 29, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	3,948,886	Change	-2.62%

Jun-30-25 07:22AM	FOXO TECHNOLOGIES INC.'S BEHAVIORAL HEALTH SUBSIDIARY HAS BEEN APPROVED TO RECEIVE SCOTT COUNTY OPIOID ABATEMENT FUNDS (GlobeNewswire)
Jun-27-25 07:27AM	FOXO TECHNOLOGIES INC. DESIGNATES NEW SERIES OF PREFERRED STOCK TO BE USED FOR ACQUISITIONS (GlobeNewswire) -7.38%
Jun-17-25 08:07AM	FOXO TECHNOLOGIES INC.'S CRITICAL ACCESS HOSPITAL ANNOUNCES NEW WOUND CARE SERVICES OFFERING (GlobeNewswire)
Jun-16-25 07:43AM	FOXO TECHNOLOGIES INC. CREATES ACQUISITION VEHICLE AND APPOINTS NEW INTERIM CFO (GlobeNewswire)
Jun-04-25 08:08AM	FOXO TECHNOLOGIES INC. COMPLETES EQUITY FUNDING AGREEMENT (GlobeNewswire)
08:05AM	Loading…
May-19-25 08:05AM	FOXO TECHNOLOGIES INC.'S CRITICAL ACCESS HOSPITAL ANNOUNCES EXPANSION OF SERVICES TO INCLUDE WOUND CARE (GlobeNewswire) -7.36%
May-06-25 08:05AM	FOXO TECHNOLOGIES INC.'S BEHAVIORAL HEALTH SUBSIDIARY REACHES KEY OPERATIONAL MILESTONES (GlobeNewswire) +153.10%
Apr-29-25 10:05AM	FOXO TECHNOLOGIES INC. ANNOUNCES COMPLETION OF REVERSE STOCK SPLIT (GlobeNewswire) +12.38%
Apr-17-25 05:00PM	FOXO TECHNOLOGIES INC. ANNOUNCES REVERSE STOCK SPLIT (GlobeNewswire) -22.84%
Apr-16-25 05:45PM	FOXO TECHNOLOGIES INC. ANNOUNCES FILING OF ITS ANNUAL REPORT ON FORM 10-K (GlobeNewswire)
Mar-19-25 08:07AM	FOXO TECHNOLOGIES INC. ANNOUNCES EXECUTION OF A NON BINDING AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC. (GlobeNewswire)
Mar-12-25 08:10AM	FOXO TECHNOLOGIES INC. PROVIDES UPDATE ON ITS BEHAVIORAL HEALTH SUBSIDIARY, MYRTLE RECOVERY CENTERS, INC. (GlobeNewswire)
Feb-24-25 08:10AM	FOXO TECHNOLOGIES, INC. ANNOUNCES EXECUTION OF A NON-BINDING ACQUISITION AGREEMENT FOR TWO ASSISTED-LIVING FACILITIES IN FLORIDA FOR A TOTAL CONSIDERATION OF $60 MILLION (GlobeNewswire)

FOXO Technologies, Inc. develops genetic sequencing technology, artificial intelligence and bioinformatics tools. It operates through the FOXO Labs and FOXO Life segments. The FOXO Labs segment is involved in research and development and is commercializing proprietary epigenetic biomarker technology. The FOXO Life segment is involved in combining life insurance with a dynamic molecular health and wellness platform. The company was founded on April 27, 2020 and is headquartered in West Palm Beach, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
Kr8 ai Inc.	10% Owner	Jul 22 '24	Sale	0.25	1,300,000	325,000	Jul 24 04:00 PM
WHITE MARK BRIAN	Interim CEO	Jul 22 '24	Sale	0.25	1,300,000	325,000	Jul 24 04:00 PM
WARD MARTIN CHRISTOPHER	Interim CFO	Jul 22 '24	Sale	0.25	1,300,000	325,000	Jul 24 04:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

FOXO

FOXO Technologies Inc

Upgrade your FINVIZ experience